108867000: Sulfacetamide sodium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with sulfonamide structure and antibacterial mechanism of action (substance)\Sulfacetamide sodium

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with sulfonamide structure and antibacterial mechanism of action (substance)\Sulfacetamide sodium

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Sulfone (substance)\Sulfonamide (substance)\Substance with sulfonamide structure and antibacterial mechanism of action (substance)\Sulfacetamide sodium

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Sulfonamide (substance)\Substance with sulfonamide structure and antibacterial mechanism of action (substance)\Sulfacetamide sodium

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Sulfonamide (substance)\Substance with sulfonamide structure and antibacterial mechanism of action (substance)\Sulfacetamide sodium

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sulfacetamide sodium	Is a	Product containing sulfacetamide (medicinal product)	false	Inferred relationship	Some
Sulfacetamide sodium	Is a	Sulfacetamide (substance)	false	Inferred relationship	Some
Sulfacetamide sodium	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Sulfacetamide (substance)	true	Inferred relationship	Some
Sulfacetamide sodium	Is a	Substance with sulfonamide structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Sulfacetamide sodium	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sulfacetamide sodium 10% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Sulfacetamide sodium 10% ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Sulfacetamide sodium 150 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone acetate + sulfacetamide sodium 0.2%wv/10%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Phenylephrine hydrochloride + sulfacetamide sodium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Sulfacetamide 10% eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone acetate + sulfacetamide sodium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Prednisolone acetate + sulfacetamide sodium 0.5%ww/10%ww ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Sulfacetamide sulfate + sulfur	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sulfacetamide sodium	Inferred relationship	Some
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 150 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 150 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 100 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 100 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 200 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 200 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 60 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 60 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 25 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfacetamide sodium 25 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sulfacetamide sodium	Inferred relationship	Some	1
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sulfacetamide sodium	Inferred relationship	Some	1

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
173401019	Sulfacetamide sodium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
605591012	Sulfacetamide sodium (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
364701000195111	sulfacetamide sodica	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
842551000172114	sulfacétamide sodique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
3338361001000110	Sulfacetamid-Natrium	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module